Episode 6 - IDH & MGMT explained

<p>Hello! This episode was recorded after my most recent trip to the hospital for my treatment and despite taking a nap, I was still a little tired. I just wanted to record something that night and it helps me keep my mind active. The links for the studies will all be posted here as well as on the website braincancerpodcast.com so feel free to check it out. </p> <p>What do you want to hear on the next episode? Let me know and thank you so much for listening!</p> <p> </p> <p>Chris</p> <p>Articles referenced:</p> <p><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868995/'>Gene markers study by NIH</a></p> <p><a href='https://www.fredhutch.org/en/news/center-news/2017/05/glioma-study-links-immune-response-prognosis.html'>How mutations in a single gene alter the course of a deadly brain cancer</a></p> <p><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618997/'>IDH study by the NIH</a></p> <p><a href='https://www.sciencedaily.com/releases/2014/02/140203131520.htm'>Gene mutation defines brain tumors that benefit from aggressive surgery</a></p> <p><a href='https://www.primeoncology.org/glossary/mgmt-methylated/'>MGMT Methylated</a></p> <p><a href='https://www.mayocliniclabs.com/test-catalog/Clinical+and+Interpretive/36733'>MGMT Promoter Methylation, Tumor</a></p> <p><a href='https://www.nejm.org/doi/full/10.1056/NEJMoa043331'>MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma</a></p> <p><a href='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792931/'>Personalized treatment strategies in glioblastoma: MGMT promoter methylation status</a></p> <p><a href='https://www.abta.org/tumor_types/glioblastoma-gbm/'>Glioblastoma (GBM)</a></p>